Other interstitial pulmonary diseases with fibrosis
ICD-10 J84.1 is a used to indicate a diagnosis of other interstitial pulmonary diseases with fibrosis.
J84.1 refers to other interstitial pulmonary diseases with fibrosis, which encompasses a variety of lung conditions characterized by inflammation and scarring (fibrosis) of the lung interstitium. Clinically, patients may present with progressive dyspnea, chronic cough, and reduced exercise tolerance. The anatomy involved primarily includes the alveolar walls and surrounding connective tissue, which become thickened and stiff due to fibrosis, impairing gas exchange. Disease progression can vary, with some patients experiencing rapid deterioration while others may have a more indolent course. Diagnostic considerations include high-resolution computed tomography (HRCT) scans, pulmonary function tests (PFTs), and sometimes lung biopsy to confirm the diagnosis and rule out other conditions. It is crucial to differentiate J84.1 from other interstitial lung diseases (ILDs) such as idiopathic pulmonary fibrosis (IPF) and sarcoidosis, as management strategies may differ significantly.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J84.1 includes various interstitial lung diseases that lead to fibrosis, such as hypersensitivity pneumonitis, asbestosis, and drug-induced lung disease. Each condition may have specific diagnostic criteria based on clinical history, exposure, and imaging findings.
J84.1 should be used when the interstitial pulmonary disease is confirmed to have fibrosis but does not fit the criteria for more specific codes like J84.0. It is essential to document the clinical context and any relevant diagnostic findings.
Documentation should include a thorough clinical history, results from pulmonary function tests, HRCT imaging findings, and any biopsy results if performed. Clear notes on the patient's symptoms and progression of the disease are also critical.
